Sign in

NCT06209970Completed

35kDa Hyaluronan Fragment Treatment of Colorectal and Rectal Cancer

Injection of 35kDa Hyaluronan Fragment Alleviates Pain Associated With Radiotherapy for Treatment of Colorectal and Rectal Cancer

Source: ClinicalTrials.gov · Last updated 17 Apr 2024

Brief summary (registry, in English)

HA35 (Bioactive HA or B-HA or HA35) have good tissue permeability (B-HA injection, Ministry of Health, Registration number L20200708MP07707). HA35 might not lose HA's bioactivities of binding to a variety of hyaluronan's binding proteins or receptors, including the analgesic and anticancer effects of hyaluronan, therefore being named bioactive HA or B-HA (10) (B-HA injection, Ministry of Health, Registration number L20200708MP07707).

Status (registry)
Completed
Study type
Interventional
Enrollment
10 (actual)
First submitted
18 Dec 2023
Start date
20 Dec 2023
Primary completion date
1 Feb 2024
Lead sponsor
Nakhia Impex LLC
NCT number
NCT06209970

What you commit to

  • Study type: Interventional
  • Participants enrolled: 10
  • From 20 Dec 2023 to the primary completion date, 1 Feb 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Severe bleeding and severe inflammation

Other

  • Can not independently determine the level of pain.

Who the study is looking for

  • All patients had different degrees of metastasis of the cancers, including bone metastasis.
  • All patients undergo targeted radiotherapy shortly before this study.
  • All the patient volunteers included in this study were allowed to use antibiotic compounds on and off during the treatment in order to prevent possible infection associated with the cancers for ethnic consideration.
  • The included patients were aged 48 to 60 years.

Age in the registry: 48 years to 60 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Qingdao Huinorde Science and Technology Co.,Ltd
Coordinator of this site? Confirm its status
QingdaoChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.